drugset
Drugs / Ferrous Bisglycinate
last change Jun 2018 re-read 2 minutes ago

Ferrous Bisglycinate

also known as Bisglycino-iron(ii) chelate · Ferrochel · Ferrous glycinate · Iron bis-glycinate chelate · Iron bisglycinate · Pharaferro 27 tablets
Developed for
iron deficiency anemia · anemia
Investigated by
Hatem AbuHashim

Trials 1 · a red edge is where a trial was stopped

today NCT03378791 · Ph 3
20162017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT03378791 Dec 2015 → Oct 2017 iron deficiency anemia Hatem AbuHashim Completed No outcome recorded
Also used as a comparator or background therapy in 2 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 31 trial
Phase 3 NCT03009578 Comparator Feb 2017 → Apr 2018 anemia Assiut University Completed No outcome recorded
Phase 41 trial
Phase 4 NCT02590224 Comparator Jan 2016 → Jul 2017 iron deficiency anemia Assiut University Completed No outcome recorded

Evidence & citations 8 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as ferrous bis-glycinate “Women will receive oral ferrous bis-glycinate fully reacted amino acid 27 mg tablets” NCT03009578 ↗
2

NCT03009578 ↗

NCT02590224 ↗
Known as Bisglycino-iron(ii) chelate ChEMBL registry synonym — accepted as the source's own label CHEMBL4297753 ↗
Known as Ferrochel ChEMBL registry synonym — accepted as the source's own label CHEMBL4297753 ↗
Known as Ferrous glycinate ChEMBL registry synonym — accepted as the source's own label CHEMBL4297753 ↗
Known as Iron bis-glycinate chelate ChEMBL registry synonym — accepted as the source's own label CHEMBL4297753 ↗
Known as Iron bisglycinate ClinicalTrials.gov intervention name — accepted as the source's own label NCT03378791 ↗
Known as Pharaferro 27 tablets “The patients will receive oral ferrous bis-glycinate fully reacted amino acid 27 mg tablets (Pharaferro 27 tablets) once daily for eight consecutive weeks.” NCT02590224 ↗
Route Oral “The patients will receive oral ferrous bis-glycinate fully reacted amino acid 27 mg tablets (Pharaferro 27 tablets) once daily for eight consecutive weeks.” NCT02590224 ↗